Triptorelin embonate Prescribing at JESMOND HEALTH PARTNERSHIP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
57
Total Quantity
57
NHS Cost
£23.6K
vs National Avg
+472.6%
JESMOND HEALTH PARTNERSHIP prescribed 57 items of Triptorelin embonate over the last 12 months at a cost of £23,573 to the NHS. This is 472.6% above the national average prescribing rate. Triptorelin embonate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
2
Jul 2026
1
Jul 2026
4
Jul 2026
4
Jul 2026
5
Jul 2026
10
Jul 2026
6
Jul 2026
5
Jul 2026
5
Jul 2026
1
Jul 2026
9
Jul 2026
5
Prescribing Details
| Total Items | 57 |
|---|---|
| Total Quantity | 57 |
| Total NHS Cost | £23,573 |
| Presentations | 1 different forms |
| vs National Average | +472.6% |
Triptorelin embonate Prescribing Comparison
| This practice | 57 items |
|---|---|
| National average per practice | 10 items |
| Difference | +472.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.